Search
Search Results
-
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer
BackgroundThe objective of this study was to evaluate the prognostic value of early PSA decline following initiation of second-generation hormone...
-
Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER
PurposeMalignant phyllodes tumor of the breast (MPTB) is a rare type of breast cancer, with an incidence of less than 1%. The value of adjuvant...
-
Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool
BackgroundPrognostic indicators, treatments, and survival estimates vary by cancer type. Therefore, disease-specific models are needed to estimate...
-
Body composition and cancer survival: a narrative review
Interest in understanding the relationship between body composition and cancer survival has remained strong for decades, with a number of recent...
-
Cancer-specific survival in patients with cholangiocarcinoma after radical surgery: a Novel, dynamic nomogram based on clinicopathological features and serum markers
BackgroundThis study aims to (1) identify preoperative testing-based characteristics associated with enhanced prognosis and survival for...
-
Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer
BackgroundMultivitamin use is common among cancer patients. Whether post-diagnostic multivitamin supplementation is beneficial for prostate cancer...
-
Identification of Plasma Metabolites Associated with Lung Cancer Survival
Limited knowledge has been reported regarding the performance of plasma metabolomics for predicting lung cancer prognosis. In this chapter, we...
-
Exploration of subtype-specific perturbations in breast cancer
Breast cancer remains a leading cause of mortality among women, characterized by its complex and diverse nature, comprising various molecular...
-
Vitamin D status during and after treatment and ovarian cancer survival
PurposeFive-year relative survival for ovarian cancer remains below 50%. Strategies to improve outcomes are needed. Higher serum 25-hydroxyvitamin D...
-
Time-varying associations of patient and tumor characteristics with cancer survival: an analysis of SEER data across 14 cancer sites, 2004–2017
PurposeSurveillance, Epidemiology, and End Results (SEER) cancer registries provides information about survival duration and cause of death for...
-
15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer
BackgroundAn informed decision regarding a treatment option requires data on its long-term efficacy and side-effect profile. While the side-effects...
-
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
Genomics has greatly improved how patients with cancer are being treated; however, clinical-grade genomic biomarkers for chemotherapies are currently...
-
Biomarkers in Cancer Survival and Drug Resistance
Cancer survival and resistance biomarkers are biological molecules which are distributed in different tissues or fluids of the body, they can be...
-
Integrated In Silico Analysis of Proteogenomic and Drug Targets for Pancreatic Cancer Survival
Pancreatic cancer remains a major health concern, being among the deadliest forms of cancer with over 80% of the patients presenting with metastatic...
-
Survival mechanisms of circulating tumor cells and their implications for cancer treatment
Metastasis remains the principal trigger for relapse and mortality across diverse cancer types. Circulating tumor cells (CTCs), which originate from...
-
Identification of unique rectal cancer-specific subtypes
BackgroundExisting colorectal cancer subty** methods were generated without much consideration of potential differences in expression profiles...
-
Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival
BackgroundInformation about survival by stage in bladder cancer is scarce, as well as about survival of non-invasive bladder cancer. The aims of this...
-
Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer
BackgroundTissue-resident memory T (Trm) cells are associated with cytotoxicity not only in viral infection and autoimmune disease pathologies but...
-
Association of high-risk comorbidity with overall survival among patients with gastric cancer and its sex-specific differences in China: a retrospective observational cohort study
BackgroundConcomitant diseases often occur in cancer patients and are important in decision-making regarding treatments. However, information...
-
Aspirin use and head and neck cancer survival and recurrence
BackgroundHead and neck cancer (HNC) has low 5-year survival, and evidence-based recommendations for tertiary prevention are lacking. Aspirin...